Endocrine effects of naloxone-induced opiate receptor blockade.
D000328:Adult; D001120:Arginine; D001786:Blood Glucose / Q000032:analysis; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006728:Hormones / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007328:Insulin / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D009270:Naloxone; D010908:Pituitary Hormones, Anterior / Q000097:blood; D011388:Prolactin / Q000097:blood; D011957:Receptors, Opioid / Q000378:metabolism*; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone
D001786:Blood Glucose; D006728:Hormones; D007328:Insulin; D010908:Pituitary Hormones, Anterior; D011957:Receptors, Opioid; D009270:Naloxone; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D005934:Glucagon; D001120:Arginine; D006854:Hydrocortisone